Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in artificial intelligence dealmaking
2.1. Introduction
2.2. Artificial intelligence partnering over the years
2.3. Most active artificial intelligence dealmakers
2.4. Artificial intelligence partnering by deal type
2.5. Artificial intelligence partnering by therapy area
2.6. Deal terms for artificial intelligence partnering
2.6.1 Artificial intelligence partnering headline values
2.6.2 Artificial intelligence deal upfront payments
2.6.3 Artificial intelligence deal milestone payments
2.6.4 Artificial intelligence royalty rates

Chapter 3 - Leading artificial intelligence deals
3.1. Introduction
3.2. Top artificial intelligence deals by value

Chapter 4 - Most active artificial intelligence dealmakers
4.1. Introduction
4.2. Most active artificial intelligence dealmakers
4.3. Most active artificial intelligence partnering company profiles

Chapter 5 - Artificial intelligence contracts dealmaking directory
5.1. Introduction
5.2. Artificial intelligence contracts dealmaking directory

Chapter 6 - Artificial intelligence dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices
Appendix 1 - Artificial intelligence deals by company A-Z
Appendix 2 - Artificial intelligence deals by stage of development
Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation

Appendix 3 - Artificial intelligence deals by deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Research
Spin out
Sub-license
Supply
Technology transfer

Appendix 4 - Artificial intelligence deals by therapy area
Cardiovascular
Central Nervous System
Genetic disorders
Hematology
Immunology
Infectives
Metabolic
Musculoskeletal
Obstetrics
Oncology
Ophthalmics
Orphan disease
Pediatrics
Respiratory

Appendix 5 -Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures
Figure 1: Artificial intelligence partnering since 2010
Figure 2: Active artificial intelligence dealmaking activity since 2010
Figure 3: Artificial intelligence partnering by deal type since 2010
Figure 4: Artificial intelligence partnering by disease type since 2010
Figure 5: Artificial intelligence deals with a headline value
Figure 6: Artificial intelligence deals with an upfront value
Figure 7: Artificial intelligence deals with a milestone value
Figure 8: Artificial intelligence deals with a royalty rate value
Figure 9: Top artificial intelligence deals by value since 2010
Figure 10: Most active artificial intelligence dealmakers since 2010
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events

Companies mentioned
1ST Biotherapeutics, 3Derm Systems, 23andMe, A*STAR Bioinformatics Institute, A.I. Squared, A2A Pharmaceuticals, Abramson Cancer Center, AcuraStem, Adapt Analytics, Adaptive Biotechnologies, Adents, Adventist Health, Adventus Ventures, Adynxx, Aether, Ai-Medic Devices, AiCure, Aiforia Technologies, AIkido Pharma, Aitrics, AKESOgen, Alberta Health Services, Alberta Innovates Bio Solutions, Alberta Innovates Technology Futures, Al Bio Tech, Alexion Pharmaceuticals, AlgoMedica, Align Technology, AliveCor, Alliance For Clinical Trials In Oncology, Almirall, ALS Association, AltaML, Althea Technologies, Alverno Clinical Laboratories, Amazon Web Services, American Sleep Apnea Association, Amgen, Amitech Solutions, Amyris, Analytics Engines, AnchorDx, Anthem, Applied BioMath, ArcherDX, Arctoris, Ares Genetics, Arm, Arterys, ARUP Laboratories, Asimily, Astellas Pharma, AstraZeneca, Atomwise, Atrapos Therapeutics, ATUM, AUM Biotech, Auransa, Auron Therapeutics, Automation Anywhere, Avera Health, AXA PPP healthcare, Ayasdi, BAMF Health, BASF, Bausch & Lomb, Bayer, Bay Labs, BCG Digital Ventures, BC Platforms, Beckman Coulter, Becton Dickinson, Beijing Tide Pharmaceutical, BenevolentAI, Benson Hill Biosystems, Berg, BERG Analytics, Berg Pharma, Bill and Melinda Gates Foundation, BioBeats, BioBright, Biocept, BioDuro, Biofourmis, Biomedical Advanced Research and Development Authority, BioMotiv, Biorelate, BioSig Technologies, BioSymetrics, Bioz, Bird Foundation, Blackford, BlackThorn Therapeutics, Blockshine Technology, Bloqcube, Body Labs, Boehringer Ingelheim, BostonGene, Brainomix, BrainScope, Bridge Biotherapeutics, Brigham and Women's Hospital, Bristol-Myers Squibb, Broad Institute, Brown University, BullFrog AI, BurstIQ, C4X Discovery, California Institute for Biomedical Research, Cancer Genetics, Cancer Research UK, Cannabics Pharmaceuticals, Canopy Biosciences, Cardinal Analytx Solutions, Cardiowise, Caresyntax, Carnegie Mellon University, CAS, Ceapro, Celgene, Cellgen Diagnostics, Center for Prostate Disease Research, Centers for Medicare and Medicaid Services, Centogene, Centre Leon Berard, Cerevel Therapeutics, Cernostics, Certis, Charles River Laboratories, CHDI Foundation, ChemDiv, Chemi Pharmaceutical, Children's Hospital Boston, Children's Hospital of Philadelphia, Children's National Health System, Children's Center for Cancer and Blood Diseases (CCCBD), China Oncology Focus, Christian Doppler Research Association, City of Hope, Claritas HealthTech, Cleveland Clinic, CLEW Medical, Client Outlook, Clinical Research Strategies, Clinigen, Cloudera, Cloud Pharmaceuticals, Cogia Biotech, Cognetivity Neurosciences, Cognoa, Cohen Veterans Bioscience, Columbia University, Concerto HealthAI, Consortium AI, Control Flo Medical, COPAN, CoreBiome, Covaris, Crothall Healthcare Technology Solutions, CrystalGenomics, CureMetrix, Cures Within Reach, Current Health, Cyclica, Cytobank, CytoReason, Dacadoo, Daewoong Pharmaceutical, Dana-Farber Cancer Institute, DarwinHealth, Dascena, DASH Analytics, Data2Life, DataRobot, Datavant, DEARhealth, Deciphex, DecisionQ, DEEP 6 AI, Deep Cube, Deep Lens, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Definiens, Department of Defense, Department of Energy, Department of Veterans Affairs, DePuy, Desktop Genetics, Diagnos, Diagnostic Robotics, DiA Imaging Analysis, Diurnal, Draper Laboratories, Drugs for Neglected Diseases Initiative, Duality Technologies, e-NIOS, E-Therapeutics, Early Signal Foundation, Edison Nation, Edwards Lifesciences, eKare, Eko, Elevian, Eli Lilly, Elucidata, Emory University, Empirico, Enamine, Endpoint Health, EndPoint Technologies, EnvoyAI, Esaote, European Board and College of Obstetrics and Gynaecology, Evidation Health, Evotec, Ewha Womans University, Excelra, ExScientia, Fabric Genomics, FDNA, Fio, Flo Health, Food and Drug Administration (FDA), Freenome, Fresenius Medical Care, Fujifilm medical systems, Fujitsu Laboratories, Fujitsu Laboratories of America, Fusion Antibodies, Garuda Health Services, Gatehouse Bio, GC Pharma, GDM Seeds, GE Healthcare, Geisinger Health System, Genentech, Genetic Technologies, Geneva University Hospitals, GenomeSmart, Genomics, Genomics England, Genomic Testing Cooperative, Genpact, Georgia Institute of Technology, German Research Center for Artificial Intelligence, Gestalt Diagnostics, Getinge, Gilead Sciences, Ginkgo BioWorks, Glassbeam, GlaxoSmithKline, Global Good Fund, Gnosis Bioresearch, GNS Healthcare, Google, Govzilla, Greenville Health System, GT Apeiron Therapeutics, Guerbet, Haga Teaching Hospital, Halo Dx, Hancom Group, Happy Life Tech, Harvard University, Healius, HealthCare Konnect, HealthLytix, HealthPointe Solutions, Health Services Advisory Group, Healx, Helsinki University Central Hospital (HUCH) Comprehensive Cancer Center, Henry M. Jackson Foundation, Hill-Rom, Hitachi, Horizon Discovery, Huawei, Humana, Human Longevity, I-Dante, Ibex Medical Analytics, iBio, IBM, IBM Watson Health, IDx, iFLYTEK, Iktos, Illumina, Image Analysis, Imagia, Imalogix, Immuneering, InContext.ai, INC Research, Indivumed, Ingenza, Innoplexus, Innovate UK, Innovative Medicines Initiative (IMI), Inovalon, Inova Translational Medicine Institute, Insel Gruppe, Insilico, Insilico Medicine, Insitro, Institute of Cancer Research, Integra LifeSciences, Intel, Intellegens, Interprotein, InterSystems, inviCRO, Ionis Pharmaceuticals, IQVIA, Iris Pharma, IrisVision, IronHealth, Israeli National Authority for Technological Innovation, Itus, Janssen Alzheimer Immunotherapy, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Agency for Medical Research and Development, J Craig Venter Institute, Jewish General Hospital, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, John Wiley and Sons, Juvenescence, Jvion, Kaiser Permanente, Kantar Health, Karuna Therapeutics, KBP BioSciences, Kebotix, Keen Eye, KemPharm, Kings College London, Kirin, Konica Minolta, KYAN Therapeutics, Kyoto University, Laboratory Corporation of America, Labrador Technologies, LabTwin, La Jolla Institute for Allergy & Immunology, Lark Technologies, Leidos Holdings, Les Laboratoires Servier, Lieber Institute, LifeArc, Life Image, Lumme, Lundbeck, Lunit, Lygos, MAbSilico, Mach7 Technologies, Mannin Research, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mateon Therapeutics, Max-Planck, MaxQ AI, Mayo Clinic, McGill University, Medable, Medial, Medial EarlySign, MEDIAN Technologies, Medical University of Graz, Medicines and Healthcare Products Regulatory Agency, Medidata Solutions, Medipath, MediTechnix, Medopad, MedyMatch, Melax Technologies, Memorial Sloan Kettering Cancer Center, Mendel.ai, Mendel Health, Merck KGaA, Meridian IT, Metaoptima Technology, Michael J Fox Foundation, Michigan State University, Microsoft, MILA International, Milner Therapeutics Institute and Consortium, MindPeak, Mindstrong Health, MITRE, Mitsui, Molecular Health, Molplex Pharmaceuticals, Monsanto, MORE Health, Motic, Mount Sinai Health System, Multiple Myeloma Research Foundation, Mundipharma, MyHealios, Myovant Sciences, Myriad Genetics, Nankai Hospital, Nano-X Imaging, Nano Global, National Cancer Center of Japan, National Center for Advancing Translational Sciences (NCATS), National Center for Tumor Diseases, National Healthcare Services (NHS), National Heart, Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute on Aging, National Institutes of Health, National Science Foundation, National University of Singapore, NEC, Neiman Institute, NeoX Biotech, Nestle, NetraMark, NetraPharma, NeuroLogica, Neuropore Therapies, New England Biolabs, New Jersey Innovation Institute, Nference, NHS Scotland, Nico, NorthBay Healthcare, Northeastern University, Northern Arizona Healthcare, Northwestern Medicine Bluhm Cardiovascular Institute, Norwegian Research Council, Novant Health, Novartis, NTT Data, NTT Medical Center Tokyo, Nuance Healthcare, Nucleai, NuMedii, Numerate, Nuritas, Nvidia, Nyansa, NYU Langone Medical Center, OKRA Technologies, Olea Medical, Omnicell, Oncodesign, OncoHost, OncoStatyx, One Drop, Onegevity, OnFace, Ono Pharmaceutical, Open Commons Consortium, Optibrium, Optima Solutions Holdings, OptraHEALTH, Origenis, OSE Immunotherapeutics, Oslo University Hospital, Owkin, Oxford Genetics, Oxford Sciences Innovation, Paige, Pancreatic Cancer Collective, Parallax Health Sciences, Pareto Biotechnologies, Parexel, Parkinson's Institute, PathAI, Pathway Genomics, Penn Medicine, Pennsylvania Department of Health, PeptiDream, PercayAI, PeriGen, PerkinElmer, Pfenex, Pfizer, PGI Drug Discovery, Pharnext, Phenome Networks, Phenomics Health, PhoreMost, PhysIQ, PicnicHealth, Ping An Ventures, Pluristem Therapeutics, PolarisQB, Porton Pharma Solutions, PPD, Precera Bioscience, Precision Innovation Network, Premier Health Group, Prescient Medical, PrimeVigilance, Procter & Gamble, Prognos, Proscia, Protagen, Protean BioDiagnostics, Proteona, Protxx, PsychoGenics, Purdue Research Foundation, Qiagen, Qu & Co, Qure.ai, R1 RCM, Radiology Oncology Systems, RadNet, Rady Children's Institute for Genomic Medicine, RayBiotech, ReadCoor, Recursion, Regenstrief Institute, Reified Capital, Relation Therapeutics, Relay Medical, Reliq Health, RenalytixAI, RENX AI Labs, Repurpose.AI, Research Institute of McGill University Health Centre (RI MUHC), Reveal Biosciences, Reverie Labs, ReviveMed, Revive Therapeutics, Revon Systems, Rhythm Pharmaceuticals, Roam Analytics, Roche, Royal Philips Electronics, Rush University Medical Center, Saama, Salud Digna, Salud Interactiva, Samsung Electronics, Sanofi, Santen, Sanuwave Health, Sartorius, Schrodinger, Scripps Research Institute, Second Genome, Sectra, Seedo, Selah Genomics, Selecta Biosciences, Sema4, SEngine Precision Medicine, Sensyne Health, Serametrix, Seven Bridges Genomics, Sheikh Zayed Institute for Pediatric Surgical Innovation, Siemens Healthineers, SilverCloud Health, SK Biopharmaceuticals, SmartAction, snap40, Socionext, SOINN, SomaLogic, SOM Biotech, Sonoma Orthopedic Products, Sonora Quest Laboratories, Sophia Genetics, Soricimed Biopharma, Spanish National Cancer Research Centre, Splice Machine, Standigm, Stanford University, Stanford University School of Medicine, StemoniX, Stonehaven Incubate, Sun Yat-sen University, Susan G. Komen for the Cure, Synchronous Health, Syneos Health, Takeda Pharmaceutical, TARA Biosystems, Techcyte, TELUS Ventures, Tempus, Tencent Holdings, TenX Biopharma, TeraRecon, Terason, Teva Pharmaceutical Industries, TheraSim, The University of Chicago Medicine, ThinkCyte, Thomson Reuters, Tissue Analytics, Topcon, Transgene, Translational Drug Development, Trethera, TTP Group, Twist Bioscience, twoXAR, Ubic, UCB, UiPath, Ultivue, UMass Memorial Medical Center, uMETHOD Health, Uniformed Services University of the Health Sciences, United Imaging Healthcare, Universite Laval, University Medical Center Groningen, University Medical Center Utrecht, University of California, Davis, University of California, San Diego, University of California Los Angeles, University of California San Francisco, University of Connecticut, University of Hong Kong, University of Maryland Baltimore, University of Miami, University of Michigan, University of Montreal, University of Oxford, University of Pittsburgh, University of Quebec, University of Sherbrooke, University of the Highlands and Islands, University of Tokyo, UPMC, US Veterans Administration, Utah Genome Project, Valeant Pharmaceuticals, Valisure, Vanderbilt University, Varian Medical Systems, VeChain, Veeva Systems, Verb Surgical, Vertex Pharmaceuticals, Vida Diagnostics, VieCure, Vir Biotechnology, Visage Imaging, VisiQuate, Vitaccess, VitalConnect, Viviphi, Viz.ai, WakeMed Health & Hospitals, Walter Reed Army Institute of Research, Ward Medication Management, Warp Drive Bio, Washington University in St Louis, Whiterabbit, Windber Research Institute, WinterLight Labs, World Health Organization, Worldwide Clinical Trials, Worthington Biochemical Corporation, Wound Care Advantage, Wuxi Apptec Laboratory Services, WuXi NextCODE Genomics, Wyss Institute, X-chem, Xencor, Xenon Pharmaceuticals, XtalPi, Yale School of Medicine, Yuhan Corporation, ZebiAI Therapeutics, Zebra Medical Vision